A team at Cancer Research UK claim to have moved a step closer to developing the test that will help identify men at risk of getting prostate cancer after it discovered that a protein found in urine is affected by a genetic change linked to the disease.
However,more research is needed,but their work could lead to the development of a reliable test costing 5.50 pounds,the ‘BBC News’ reported.
The scientists showed that the protein,called MSMB,is present at reduced levels in men diagnosed with the disease. Levels also appear to be affected by tumour aggressiveness.
Study leader Dr Hayley Whitaker said: “We looked in tissue and urine from over 350 men with and without prostate cancer to find out how much MSMB they had.
“The protein is easy to detect because it is found in urine and would potentially be a very simple test to carry out. We then looked to see who had the genetic change. It was really exciting to find out that the genetic change and the amount of protein were linked.
“The protein is easy to detect because it is found in urine and would potentially be a very simple test to carry out on men to identify those most at risk of developing the disease.”
Experts have welcomed the research published in the ‘Public Library of Science ONE’ journal.
Dr Kate Holmes,research manager at The Prostate Cancer Charity,described the test as “potentially a powerful way to predict how likely a man is to develop prostate cancer”.